The what, when, and why of human prostate cancer xenografts-Reference-Cited by-同舟云学术

The what, when, and why of human prostate cancer xenografts

Published:2018-03-24 Issue:9 Volume:78 Page:646-654
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Brennen W. Nathaniel¹,Isaacs John T.¹

Affiliation:

1. Department of Oncology, Prostate Cancer Program; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine; Baltimore Maryland

Publisher

Wiley

Subject

Urology,Oncology

Reference49 articles.

1. They Do Exist

2. Increased survival of xenogeneic tumors in thymectomized hosts;Grogan;J Surgical Res,1968

3. Report;Isaacson;Mouse News Letter,1962

4. 'Nude', a new hairless gene with pleiotropic effects in the mouse;Flanagan;Genet Res,1966

5. Observations on the immunobiology of 'Nude' Mice;Pantelouris;Immunology,1971

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the challenges and opportunities for using patient‐derived models in prostate cancer research;The Prostate;2024-03-07

2. Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer;Molecular Cancer Therapeutics;2024-03-05

3. The future of patient-derived xenografts in prostate cancer research;Nature Reviews Urology;2023-01-17

4. An overview of the latest in state-of-the-art murine models for prostate cancer;Expert Opinion on Drug Discovery;2021-07-05

5. Using the Microwell-mesh to culture microtissues in vitro and as a carrier to implant microtissues in vivo into mice;Scientific Reports;2021-03-04